Company profile
UK company 05635708, incorporated on 24 November 2005.
BioToolomics::Specialising in high performance bioprocessing chromatography media & disposable columns for the purification of antibody and biopharmaceutical drugs....
Biotoolomics offers ready-to-use disposable chromatography technology for the purification of biopharmaceutical drugs.Our products and services strongly focus on the core theme of “ready-to-use, disposable, high performance and high flexibility.”
Company number 05635708
Financial period: 1 Jan 2024 to 31 Dec 2024
Reference milestones and recent Companies House filing stream events.
Company registered at Companies House
1 Nov 2024 to 31 Oct 2030
PHARMECO is supported by the Innovative Health Initiative Joint Undertaking (IHI JU). The JU receives support from the European Union’s Horizon Europe research and innovation programme and COCIR, EFPIA, Europa Bío, MedTech Europe, and Vaccines Europe. The project's overall objective is to revolutionize pharmaceutical manufacturing towards sustainability b...
1 Dec 2023 to 31 Jan 2026
The manufacture of medicines was brought to the fore during the recent pandemic. The urgency of being able to produce the quantities and quality of medicine in a short period of time focussed minds across academia and industry. A further focus for the public in recent years has been the protection of our environment and introduction of practises reducing ...
1 Jun 2023 to 31 May 2024
Currently mRNA medicines are synthesized through in vitro transcription (IVT) reaction. The presence of double-stranded RNA (dsRNA) is one of the major quality concerns to mRNA medicines. Besides, the raw material cost in IVT reactions is very high but their utilisation efficiency is very low. This collaborative research project aims to use more cost-effe...
1 Apr 2019 to 31 Dec 2020
Gene therapy has formed one of the most advanced medical technology in the modern precision medicine area. It has shown some unique advantages in curing certain diseases. There is a growing demand of high quality viral medicines to be manufactured with efficient and cost-effective methods. This Research Project proposes a highly efficient chromatography b...
1 Feb 2019 to 31 Jan 2022
While biotherapeutics offer potential treatments for some of the most debilitating diseases, the development and manufacture of these potentially life changing treatments is risky, technically challenging and expensive. This project will develop novel polymer composite materials specifically for the efficient and cost-effective manufacturing of antibody d...
1 Feb 2018 to 31 Jan 2019
Gene therapy has formed one of the most advanced medical technology in the modern precision medicine area. It has shown some unique advantages in curing certain diseases. There is a growing demand of high quality viral medicines to be manufactured with efficient and cost-effective processes. This feasibility study project proposes a much efficient purific...
1 Jul 2015 to 30 Jun 2018
The current platform antibody purification process deployed in the bioprocesing industry becomes less efficient and less cost-effective to match with high titre upstream technologies. Based on previous feasibility studies using model antibodies, the key aim and objective of this project is to investigate negative chromatography based technologies using re...
1 Jun 2010 to 31 Dec 2014
BioToolomics Ltd is a life science company offering cutting-edge solutions to the cost-effective purification of biopharmaceutical drugs. The project is tilted "Negative chromatography technology for the cost-effective manufacturing of antibody biopharmaceuticals". In simple term, according to this technology, an antibody drug produced in cell culture bro...
